Skip to main content
. 2019 Mar 12;9:4259. doi: 10.1038/s41598-019-39241-y

Table 2.

Acute and Subacute Adverse Effects.

Grade 1–2 Grade 3–5
Dermatitis 10 (7.1%) 0
Mucositis 26 (18.4%) 0
Xerostomia 5 (3.5%) 0
Nausea 2 (1.4%) 0
Headache 1 (0.7%) 0
Hemorrhage 0 1* (0.7%)

*Excluded 1 case of hemorrhage due to confirmed rupturing of an inter-concurrent optic artery aneurysm unrelated to the disease or treatment confirmed on angiogram.